Curetis N.V. (the “Company” and, together with Curetis AG, “Curetis“), a developer of next-level molecular diagnostic solutions, today announced its participation in several major industry conferences in the first quarter of 2016. The respective investor presentations will be made available on the company’s website.
J.P. Morgan 34th Annual Healthcare Conference, January 11-14, 2016, in San Francisco, CA.: attendance of the company´s management team and one-on-one meetings
Degroof Petercam’s Healthcare Seminar, February 3, 2016, in Brussels, Belgium: management presentation
2016 RBC Capital Markets Healthcare Conference, February 23-24, 2016, in New York City, NY: management presentation
BioCapital Europe, March 9, 2016, in Amsterdam, The Netherlands: management presentation
9th Annual European Life Science CEO Forum & Exhibition, March 15-16, 2016, in Zurich, Switzerland: management presentation
36th International Symposium on Intensive Care and Emergency Medicine (ISICEM), March 15-18, 2016, in Brussels, Belgium: scientific meeting.